Citations

Clear

1011 citation(s) found for "Barry, WT".

Artificial Intelligence‐Enhanced ECG Identification of Low Ejection Fraction: A Pragmatic, Cluster‐Randomized Clinical Trial
Rushlow, David , Inselman, Jonathan , Thacher, Thomas D., Behnken, Emma , Bernard, Matthew , Rosas, Steven , Akfaly, Abdulla , Misra, Artika , Molling, Paul , Krien, Joseph, Siontis, Konstantinos C. , Shah, Nilay D., Friedman, Paul A. , Yao, Xiaoxi , McCoy, Rozalina G. , Foss, Randy , Barry, Barbara , Kapa, Suraj , Pellikka, Patricia A. , López-Jiménez, Francisco , Attia, Zachi I. , Noseworthy, Peter A.

Mayo Clinic

Health Services Research | September 15, 2021 | Volume: 56 | Issue: S2 | Pages: 28-29

10.1111/1475-6773.13757 Get It

Research ObjectiveAn artificial intelligence (AI) algorithm based on ECG was integrated into clinical workflows to identify patients with a high likelihood of low ejection (EF), a condition that is underdiagnosed but treatable. The trial aimed to assess whether the AI‐powered clinical decision support enabled early diagnosis of low EF.Study DesignA pragmatic, cluster randomized controlled trial (RCT) was conducted in 45 primary care practices, including an academic medical center as well as community and rural clinics across Minnesota and Wisconsin. A total of 120 primary care teams, including 358 clinicians, were randomized to either intervention (access to AI results with positive results indicating a high likelihood of low EF; 181 clinicians) or control (usual care; 177 clinicians). The primary endpoint was a new diagnosis of EF≤50% within 90 days. A positive deviance qualitative study and a survey were used to assess implementation strategies.Population StudiedIn total, 22,641 adult patients (N = 11,573 intervention; N = 11,068 control) with ECG performed as part of routine care between 8/5/2019 and 3/31/2020 were included. Patients were excluded if they had known EF≤50% or a history of documented heart failure (HF) identified by clinical notes abstracted by natural language processing.Principal FindingsThe mean age of patients was 60.5 ± 17.6 years; 53.9% were women. Positive AI results were found in 6.0% of patients in both arms. Clinicians in the intervention group obtained more echocardiograms for patients with positive results (38.1% control vs. 49.6% intervention, p < 0.001), but in the overall cohort, the echocardiogram utilization was similar (18.2% vs. 19.2%, p = 0.17). The intervention increased the diagnosis of low EF in the overall cohort (1.6% vs. 2.1%, odds ratio [OR] 1.32 [1.01–1.61], p = 0.007) and among patients with positive results (14.5% vs. 19.5% OR 1.43 [1.08–1.91], p = 0.01). Results using different thresholds for low EF were consistent with the primary result. Among patients with positive results, the intervention increased echocardiography more significantly in women vs. men (p for interaction 0.02), in patients without prior echocardiogram vs. those with prior echocardiogram (p for interaction 0.04), and in patients whose ECGs were ordered in outpatient clinics (p for interaction 0.02).ConclusionsAn AI algorithm run on existing ECGs enabled the early diagnosis of low EF in a large cohort of patients managed in routine primary care practices. Because ECG is a low‐cost test frequently performed for a variety of purposes, the algorithm could improve early diagnosis and treatment of a condition that is often asymptomatic but has effective treatments, and thus, reduce the disease burden in broad populations.Implications for Policy or PracticeThe current study is one of the first RCTs that demonstrated the value of AI in routine practice. Low EF confers an increased risk of HF progression and mortality. Although there are effective therapies, low EF is undiagnosed, leading to missed opportunities for treatment. EF can be readily determined by echocardiography, but the imagining test is too resource‐intensive to screen unselected populations. The AI applied to the existing ECGs could identify high‐risk patients for further assessment.Primary Funding SourceMayo Clinic.
Faculty Opinions recommendation of Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.
Borlaug, Barry A.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 8, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.740634987.793588044 Get It

Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure
Paneni, Francesco , Mazzola, Matteo , Biase, Nicolò De , Punta, Lavinia Del, Gargani, Luna , Mengozzi, Alessandro , Nesti, Lorenzo , Flammer, Andreas J. , Paneni, Francesco , Pugliese, Nicola Riccardo , Virdis, Agostino , Taddei, Stefano , Borlaug, Barry A. , Ruschitzka, Frank T. , Masi, Stefano

Mayo Clinic

European Journal of Heart Failure | August 24, 2021 | Volume: 23 | Issue: 11 | Pages: 1858-1871

10.1002/ejhf.2337 | PMID 34427016 Get It

Abstract Aims We evaluated the impact of echocardiographic epicardial adipose tissue (EAT) on cardiovascular haemodynamics, metabolic profile and prognosis in heart failure (HF) using combined cardiopulmonary‐echocardiography exercise stress. Methods and results We analysed EAT thickness of HF patients with reduced (HFrEF, n = 205) and preserved (HFpEF, n = 188) ejection fraction, including 44 controls. HFpEF patients displayed the highest EAT, while HFrEF patients had lower values than controls. EAT showed an inverse correlation with natriuretic peptides, troponin T and C‐reactive protein in HFrEF, while having a direct association with troponin T and C‐reactive protein in HFpEF. EAT was independently associated with peak oxygen consumption (VO 2 ) and peripheral extraction (AVO 2 diff), regardless of body mass index. EAT was inversely correlated with peak VO 2 and AVO 2 diff in HFpEF, while a direct association was observed in HFrEF, where lower EAT values were associated with worse left ventricular systolic dysfunction. In HFpEF, increased EAT was related to right ventriculo–arterial (tricuspid annular plane systolic excursion/systolic pulmonary artery pressure) uncoupling. After 21 months of follow‐up, 146 HF hospitalizations and 34 cardiovascular deaths were recorded in the HF population. Cox multivariable analysis supported an independent differential role of EAT in HF cohorts (interaction P = 0.01): higher risk of adverse events for increasing EAT in HFpEF [hazard ratio (HR) 1.12, 95% confidence interval (CI) 1.04–1.37] and for decreasing EAT in HFrEF (HR 0.75, 95% CI 0.54–0.91). Conclusion In HFpEF, EAT accumulation is associated with worse haemodynamic and metabolic profile, also affecting survival. Conversely, lower EAT values imply higher left ventricular dysfunction, global functional impairment and adverse prognosis in HFrEF.
Adverse right ventricular remodelling, function, and stress responses in obesity: insights from cardiovascular magnetic resonance
Lewis, Andrew , Abdesselam, Inès, Rayner, Jennifer J. , Lewis, Andrew J M , Byrne, James Patrick , Borlaug, Barry A. , Neubauer, Stefan , Rider, Oliver J.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | August 17, 2021 | Volume: 23 | Issue: 10 | Pages: 1383-1390

10.1093/ehjci/jeab175 | PMID 34453521 Get It

Abstract Aims We aimed to determine the effect of increasing body weight upon right ventricular (RV) volumes, energetics, systolic function, and stress responses using cardiovascular magnetic resonance (CMR). Methods and results We first determined the effects of World Health Organization class III obesity [body mass index (BMI) &gt; 40 kg/m2, n = 54] vs. healthy weight (BMI &lt; 25 kg/m2, n = 49) upon RV volumes, energetics and systolic function using CMR. In less severe obesity (BMI 35 ± 5 kg/m2, n = 18) and healthy weight controls (BMI 21 ± 1 kg/m2, n = 9), we next performed CMR before and during dobutamine to evaluate RV stress response. A subgroup undergoing bariatric surgery (n = 37) were rescanned at median 1 year to determine the effects of weight loss. When compared with healthy weight, class III obesity was associated with adverse RV remodelling (17% RV end-diastolic volume increase, P &lt; 0.0001), impaired cardiac energetics (19% phosphocreatine to adenosine triphosphate ratio reduction, P &lt; 0.001), and reduction in RV ejection fraction (by 3%, P = 0.01), which was related to impaired energetics (R = 0.3, P = 0.04). Participants with less severe obesity had impaired RV diastolic filling at rest and blunted RV systolic and diastolic responses to dobutamine compared with healthy weight. Surgical weight loss (34 ± 15 kg weight loss) was associated with improvement in RV end-diastolic volume (by 8%, P = 0.006) and systolic function (by 2%, P = 0.03). Conclusion Increasing body weight is associated with significant alterations in RV volumes, energetic, systolic function, and stress responses. Adverse RV modelling is mitigated with weight loss. Randomized trials are needed to determine whether intentional weight loss improves symptoms and outcomes in patients with obesity and heart failure.
Characterization and Outcomes of Hospitalized Children With Coronavirus Disease 2019: A Report From a Multicenter, Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) Registry
Bhalala, Utpal , Boman, Karen , Kumar, Vishakha K. , Retford, Lynn, Blatz, Allison M. , Dapul, Heda , Sayed, Imran A., Gharpure, Varsha , Irby, Katherine , Sanders, Ronald C., Heneghan, Julia A. , Thomas, Melissa K., Gupta, Manoj , Oulds, Franscene, Arteaga, Grace M. , Levy, Emily R. , Gupta, Neha , Kaufman, Margit, AbdelAty, Amr M. , Shlomovich, Mark , O'Meara, A M Iqbal, Kuehne, Joshua, Menon, Shina , Khandhar, Paras B., Miller, Aaron S., Barry, Suzanne, Danesh, Valerie , Zammit, Kimberly, Stulce, Casey , McGonagill, Patrick W. , Bercow, Asher, Amzuta, Ioana, Gupta, Sandeep , Almazyad, Mohammed , Pierre, Louisdon , Sendi, Prithvi , Ishaque, Sidra , Nawathe, Pooja , Lyons, Patrick G. , Bello, Imam Wada , Ari, Judith Ben, Kovačević, Tanja , Bansal, Vikas, Brinton, John T. , Rk, Kashyap, Bansal, Vikas , Kovačević, Tanja , Tierney, David M. , Polić, Branka , Markić, Joško , Asghar, Muhammad Sohaib , Galet, Colette , Carev, Dominko , Wen, Andy , Karam, Oliver , Bansal, Vikas , Levy, Emily R , Gharpure, Varsha P , Asghar, Muhammad S , Karam, Oliver , Gist, Katja M. , Tripathi, Sandeep , Chiotos, Kathleen , Verma, Sourabh , Bjornstad, Erica C. , Tofil, Nancy M. , Abdelaty, Amr, Medar, Shivanand , Khanna, Ashish , Anderson, Harry L, Akhter, Murtaza , Chen, Catherine , Walkey, Allan J. , Bihorac, Azra , Zimmerman, Jerry J. , Menon, Shina

Mayo Clinic

Critical Care Medicine | August 13, 2021 | Volume: 50 | Issue: 1 | Pages: e40-e51

10.1097/ccm.0000000000005232 | PMID 34387240 Get It

Objectives: Multicenter data on the characteristics and outcomes of children hospitalized with coronavirus disease 2019 are limited. Our objective was to describe the characteristics, ICU admissions, and outcomes among children hospitalized with coronavirus disease 2019 using Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: Coronavirus Disease 2019 registry. Design: Retrospective study. Setting: Society of Critical Care Medicine Viral Infection and Respiratory Illness Universal Study (Coronavirus Disease 2019) registry. Patients: Children (< 18 yr) hospitalized with coronavirus disease 2019 at participating hospitals from February 2020 to January 2021. Interventions: None. Measurements and Main Results: The primary outcome was ICU admission. Secondary outcomes included hospital and ICU duration of stay and ICU, hospital, and 28-day mortality. A total of 874 children with coronavirus disease 2019 were reported to Viral Infection and Respiratory Illness Universal Study registry from 51 participating centers, majority in the United States. Median age was 8 years (interquartile range, 1.25–14 yr) with a male:female ratio of 1:2. A majority were non-Hispanic (492/874; 62.9%). Median body mass index (n = 817) was 19.4 kg/m2 (16–25.8 kg/m2), with 110 (13.4%) overweight and 300 (36.6%) obese. A majority (67%) presented with fever, and 43.2% had comorbidities. A total of 238 of 838 (28.2%) met the Centers for Disease Control and Prevention criteria for multisystem inflammatory syndrome in children, and 404 of 874 (46.2%) were admitted to the ICU. In multivariate logistic regression, age, fever, multisystem inflammatory syndrome in children, and pre-existing seizure disorder were independently associated with a greater odds of ICU admission. Hospital mortality was 16 of 874 (1.8%). Median (interquartile range) duration of ICU (n = 379) and hospital (n = 857) stay were 3.9 days (2–7.7 d) and 4 days (1.9–7.5 d), respectively. For patients with 28-day data, survival was 679 of 787, 86.3% with 13.4% lost to follow-up, and 0.3% deceased. Conclusions: In this observational, multicenter registry of children with coronavirus disease 2019, ICU admission was common. Older age, fever, multisystem inflammatory syndrome in children, and seizure disorder were independently associated with ICU admission, and mortality was lower among children than mortality reported in adults.
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies
Omote, Kazunori , Verbrugge, Frederik H. , Verbrugge, Frederik H , Borlaug, Barry A.

Mayo Clinic

Annual Review of Medicine | August 11, 2021 | Volume: 73 | Issue: 1 | Pages: 321-337

10.1146/annurev-med-042220-022745 | PMID 34379445 Get It

Approximately half of all patients with heart failure (HF) have a preserved ejection fraction, and the prevalence is growing rapidly given the aging population in many countries and the rising prevalence of obesity, diabetes, and hypertension. Functional capacity and quality of life are severely impaired in heart failure with preserved ejection fraction (HFpEF), and morbidity and mortality are high. In striking contrast to HF with reduced ejection fraction, there are few effective treatments currently identified for HFpEF, and these are limited to decongestion by diuretics, promotion of a healthy active lifestyle, and management of comorbidities. Improved phenotyping of subgroups within the overall HFpEF population might enhance individualization of treatment. This review focuses on the current understanding of the pathophysiologic mechanisms underlying HFpEF and treatment strategies for this complex syndrome.